phase III clinical trial
advanced phase of a clinical trial, aimed at comparing a new treatment to an established one
Ratings
0
Nobody has rated this yet. Be the first!
Subject of
22
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial
.jpg/500px-Clinical_Trial_Participant_Receives_Injection_(34033294061).jpg)